NME2 / Nucleoside diphosphate kinase B · Western blot design guide

Design a Western Blot for NME2

Real validated NME2 Western blot protocols, expected-band and isoform facts, troubleshooting for weak or shifted signal, and recommended anti-NME2 WB antibodies. Everything you need to plan the experiment before you commit precious samples.

Evidence assembled September 2026 · For research use; verify linked source records and product datasheet before use
Western blot protocol sheet for NME2: expected band ~17.3 kDa, hero antibody M01762-1, catalog values and labelled standard workflow; separate PMC comparisons on the guide
Printable NME2 Western blot protocol sheet — expected band ~17.3 kDa, antibody M01762-1, controls and PMC citations. Open the full NME2 WB guide →

NME2 Western Blot Experimental Design Guide

Expected bands, validated protocols, controls and antibodies — the at-a-glance facts below, then the full design guide.

Must know before running
Expected band ~17.3 kDa
Observed band ~17 kDa
Gel 12% (catalog M01762-1)
Positive control ⓘ Endometrium (IHC candidate; verify WB) +4 more
Negative control ⓘ Adipose tissue (IHC candidate; verify WB)
Important caveats
Reasons your observed band may differ from the expected size.
PTM —
Caveat —
Gene-set association MSigDB C7 membership
Isoform 2 isoform(s)
Section 1

Real Curated NME2 Western Blot Protocols

The M01762-1 protocol combines labelled catalog values with standard starting conditions. Published comparisons retain their own sample, reagent and detection scope.

Recommended Western blot protocol parameters
Sample / lysatehuman LNCAP, human 293T, human PC-3 (catalog M01762-1)
Gel %12% (catalog M01762-1)
Load30 ug; reducing conditions (catalog M01762-1)
Transfera nitrocellulose membrane at 150 mA for 50-90 minutes (catalog M01762-1)
Membranenitrocellulose membrane (catalog M01762-1)
Blocking5% non-fat milk/TBS for 1.5 hour at RT (catalog M01762-1)
Primary antibodyM01762-1 · 1:500 (catalog M01762-1)
Primary incubationovernight at 4°C (catalog M01762-1)
Secondary antibodygoat anti-rabbit IgG-HRP, 1:5000 (catalog M01762-1)
Secondary incubation1.5 hour at RT (catalog M01762-1)
WashTBS-0.1%Tween 3 times with 5 minutes each (catalog M01762-1)
DetectionECL (catalog M01762-1)
Section 2

What Is the Expected NME2 Western Blot Band Size?

NME2 is predicted at 17.3 kDa and observed at ~17 kDa; the small difference has no established cause in the supplied evidence.

What am I looking at on my blot?
Band at ~17 kDa in whole-cell lysateMatches the empirical NME2 band near its 17.3 kDa predicted mass
Band near 17 kDa in a cytoplasmic fractionConsistent with NME2's cytoplasmic location
Band near 17 kDa in a nuclear fractionConsistent with NME2's nuclear location
Additional bands at other sizesCould reflect isoforms 1 and 3, but their migration is not established
💡Expected NME2 appearanceNME2 is predicted at 17.3 kDa, and antibody QC shows a band at ~17 kDa in reducing whole-cell lysates; confirm identity with an appropriate specificity control.
How each factor affects band size
UniProt predicted massPlaces the reference band near 17.3 kDa, consistent with the observed ~17 kDa band
152-residue sequenceUnderlies the supplied full-length predicted mass; no cleavage is annotated
Isoform 1Its individual mass and migration are not supplied
Isoform 3Its size may differ from isoform 1, but distinct bands are not established
Why is my band missing or off?
SituationLikely causeNext action
No band in lysateInsufficient NME2 signal or loss during transferCheck loading and transfer, then use a known positive lysate
Band higher than expectedBand identity is uncertain; no size-increasing modification is annotatedCheck reduction and denaturation, then verify specificity by NME2 depletion
Band lower than expectedDegradation or an unrelated antibody-reactive proteinPrepare fresh lysate with protease inhibitors and verify specificity by NME2 depletion
Multiple bandsIsoforms 1 and 3 are annotated, but their band positions are unknownUse isoform-specific evidence or NME2 depletion to assign bands
Weak or no signalLow NME2 abundance, poor transfer or inadequate antibody signalCheck loading and transfer and compare with a known positive lysate
Fragments below expected sizePossible sample degradation; no physiological cleavage is annotatedRepeat with fresh, protease-inhibited lysate and verify fragment identity

Sample controls for NME2 Western blot

🧪HPA-IHC candidate guidance (verify in WB): For positive controls for NME2 in Western blot, you can use endometrium tissue, which HPA rates high for NME2 expression.
Positive control: Endometrium (IHC candidate; verify WB)
Negative control: Adipose tissue (IHC candidate; verify WB)
Loading controls: Run GAPDH, β-actin, and a total-protein stain such as Ponceau alongside the samples.
⚠️Feasibility: HPA lists adipose tissue as not detected, but confirm the absence of signal in your lysate.

HPA tissue expression evidence for NME2

Comprehensive Human Protein Atlas IHC scoring per tissue. Rows are taken directly from the HPA tissue chart — click any row's HPA link to view the source.

Higher expression tissues · candidate positive controls from IHC

TissueCell typeLevelEvidenceSource
Endometrium glandular cells High Protein (IHC) HPA →
Kidney cells in tubules High Protein (IHC) HPA →
Lymph node non-germinal center cells High Protein (IHC) HPA →
Nasopharynx respiratory epithelial cells High Protein (IHC) HPA →
Prostate glandular cells High Protein (IHC) HPA →

Lower expression tissues · IHC evidence, not confirmed WB-negative controls

TissueCell typeLevelEvidenceSource
Adipose tissue adipocytes Not detected Protein (IHC) HPA →
Heart muscle cardiomyocytes Not detected Protein (IHC) HPA →
Skeletal muscle myocytes Not detected Protein (IHC) HPA →
Smooth muscle smooth muscle cells Not detected Protein (IHC) HPA →
Breast glandular cells Low Protein (IHC) HPA →
Section 3

Advanced NME2 Western Blot Tips

Deeper troubleshooting and optimisation questions for NME2, answered from its protein features.

How should NME2 band migration be interpreted?
Band shift · Use the separately labelled calculated mass and catalog-observed evidence above. A sequence annotation does not establish an observed migration shift. Verify target identity with orthogonal controls.
Could NME2 isoforms produce different bands?
Isoforms · UniProt lists isoforms 1 and 3. Isoform 3 has an alternative sequence beginning at UniProt position 1, so its migration and antibody recognition may differ from the canonical protein. Check whether the antibody recognizes both sequences before assigning bands to isoforms.
Do the supplied features support a modification-induced band shift?
PTM · No modified residues or glycosylation sites are listed in the supplied features. Those annotations therefore provide no specific modification or site to assign to a shifted band. Compare the band's behavior with antibody specificity and sample conditions before interpreting it.
Does this guide establish induction of NME2?
Induction · No general induction response is established by this guide. A pathway or gene-set association is not evidence of induction in a particular specimen. Verify the relevant treatment and control in a target-specific experiment.
What transfer method to use for NME2 Western blot?
Transfer · NME2 is a small protein with a predicted mass of 17.3 kDa. Choose transfer conditions that retain proteins near 17 kDa, and check the membrane and post-transfer gel if the band is weak or missing.
How should blocking be optimized?
Blocking · Standard workflow guidance: follow the M01762-1 datasheet where specified. Otherwise compare 5% milk or 5% BSA in TBST; for a phospho-specific assay start with BSA. Optimize background and specific signal with matched controls.
How should NME2 be quantified across cellular fractions?
Quantitation · NME2 is listed in the cytoplasm, nucleus, lamellipodium and ruffle. Quantify bands within the assay's linear range and compare like fractions, since changes in fraction composition can change the measured NME2 signal.
Why might NME2 run near 17 kDa?
Interpretation · The canonical sequence has a predicted mass of 17.3 kDa, close to the observed band near 17 kDa. The supplied features do not establish a modification or processing event that explains any small difference between calculated and apparent mass.

UniProt describes NME2 homohexamers and mixed hexamers with NME1. A higher band could prompt a check of sample preparation and antibody specificity, but the assembly annotation alone does not establish that a complex survives Western blot preparation.
Boster reagents

NME2 Western Blot Antibodies

Catalog antibodies with Western blot application and product-specific WB images. Evaluate suitability with the reported sample, controls and experimental conditions.

Real WB data Western blot analysis of NME2 using anti-NME2 antibody (M01762-1). Electrophoresis was performed on a 12% SDS-PAGE gel at 80V (Stacking gel) / 120V (Resolving gel) for 2 hours. The sample well of each lane was loaded with 30 ug of sample under reducing conditions. Lane 1: human LNCAP whole cell lysates, Lane 2: human 293T whole cell lysates, Lane 3: human PC-3 whole cell lysates, Lane 4: human MCF-7 whole cell lysates, Lane 5: rat liver tissue lysates, Lane 6: rat RH35 whole cell lysates, Lane 7: mouse liver tissue lysates, Lane 8: mouse HEPA1-6 whole cell lysates. After electrophoresis, proteins were transferred to a nitrocellulose membrane at 150 mA for 50-90 minutes. Blocked the membrane with 5% non-fat milk/TBS for 1.5 hour at RT. The membrane was incubated with rabbit anti-NME2 antigen affinity purified monoclonal antibody (M01762-1) at 1:500 overnight at 4°C, then washed with TBS-0.1%Tween 3 times with 5 minutes each and probed with a goat anti-rabbit IgG-HRP secondary antibody at a dilution of 1:5000 for 1.5 hour at RT. The signal is developed using an ECL Plus Western Blotting Substrate (Catalog # AR1196-200) with Tanon 5200 system. A specific band was detected for NME2 at approximately 17 kDa. The expected band size for NME2 is at 17 kDa.
Anti-NME2 Rabbit Monoclonal Antibody
Cat # M01762-1
Real WB data Western blot analysis of NME2 using anti-NME2 antibody (PA1830). <br>
Electrophoresis was performed on a 5-20% SDS-PAGE gel at 70V (Stacking gel) / 90V (Resolving gel) for 2-3 hours. The sample well of each lane was loaded with 50ug of sample under reducing conditions. <br>
Lane 1: rat heart tissue lysates, <br>
Lane 2: rat brain tissue lysates, <br>
Lane 3: mouse heart tissue lysates, <br>
Lane 4: mouse brain tissue lysates, <br>
After Electrophoresis, proteins were transferred to a Nitrocellulose membrane at 150mA for 50-90 minutes. Blocked the membrane with 5% Non-fat Milk/ TBS for 1.5 hour at RT. The membrane was incubated with rabbit anti-NME2 antigen affinity purified polyclonal antibody (Catalog # PA1830) at 0.5 μg/mL overnight at 4°C, then washed with TBS-0.1%Tween 3 times with 5 minutes each and probed with a goat anti-rabbit IgG-HRP secondary antibody at a dilution of 1:5000 for 1.5 hour at RT. The signal is developed using an Enhanced Chemiluminescent detection (ECL) kit (Catalog # EK1002) with Tanon 5200 system. A specific band was detected for NME2 at approximately 17KD. The expected band size for NME2 is at 17KD.
Anti-NME2 Antibody Picoband®
Cat # PA1830

Two the supplier anti-NME2 antibodies have Western blot images showing a band near the expected 17 kDa. Both list human, mouse, and rat reactivity, but the pictured samples differ; these examples do not establish performance in every tissue or cell type.

Which to pick: Choose M01762-1 for the pictured human cell lines or rat and mouse liver and cell lysates. Choose PA1830 for the pictured rat and mouse heart or brain lysates. PA1830 lists human reactivity, but its supplied blot shows only rat and mouse samples.

Source: BosterBio NME2 gene-info card — filtered to Western-blot-capable antibodies; each card shows that product's actual WB validation figure.